Prebiotic Oligosaccharide Supplementation and Faecal Short-Chain Fatty Acid Profile in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
DOI:
https://doi.org/10.5281/zenodo.22337839Keywords:
prebiotics, short-chain fatty acids, fructo-oligosaccharides, galacto-oligosaccharides, gut microbiotaAbstract
Background: Prebiotic oligosaccharides are fermented into short-chain fatty acids (SCFAs) that shape gut and metabolic health.
Objective: To synthesise randomised trial evidence on how fructo-oligosaccharide (FOS), inulin and galacto-oligosaccharide
(GOS) supplementation alters the faecal SCFA profile of healthy adults. Methods: Narrative review of randomised controlled
trials, systematic reviews and mechanistic studies retrieved from PubMed, Europe PMC and Crossref. Findings: Supplementation
consistently raises faecal bifidobacteria and total SCFA concentrations, with modest, dose- and individual-dependent shifts
toward butyrate and propionate. Conclusions: Prebiotic oligosaccharides reliably enhance colonic fermentation, but variability
limits precise dose-response conclusions.
References
Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502. doi:10.1038/nrgastro.2017.75.
Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, et al. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr. 1999;129(1):113-6. doi:10.1093/jn/129.1.113.
Walton GE, van den Heuvel EGHM, Kosters MHW, Rastall RA, Tuohy KM, Gibson GR. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr. 2012;107(10):1466-75. doi:10.1017/S0007114511004697.
Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221-7. doi:10.1136/gut.28.10.1221.
den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325-40. doi:10.1194/jlr.R036012.
Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104(Suppl 2):S1-S63. doi:10.1017/S0007114510003363.
Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11(10):577-91. doi:10.1038/nrendo.2015.128.
Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021;13(1):1897212. doi:10.1080/19490976.2021.1897212.
Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90(5):1236-43. doi:10.3945/ajcn.2009.28095.
Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29-41. doi:10.1111/1462-2920.13589.
Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 2016;7:979. doi:10.3389/fmicb.2016.00979.
Davis LMG, Martínez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One. 2011;6(9):e25200. doi:10.1371/journal.pone.0025200.
Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int. 2012;95(1):50-60. doi:10.5740/jaoacint.SGE_Macfarlane.
Le Bourgot C, Capronnier O, Graf S, Carton T. Targeting gut microbiota with short-chain fructo-oligosaccharides prebiotic fibers to support metabolic health in overweight prediabetic adults: a randomized, double-blinded, placebo-controlled study. Front Nutr. 2025;12:1718169. doi:10.3389/fnut.2025.1718169.
Bruhwyler J, Carreer F, Demanet E, Jacobs H. Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers. Int J Food Sci Nutr. 2009;60(2):165-75. doi:10.1080/09637480701625697.
Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5(4):1417-35. doi:10.3390/nu5041417.
Depeint F, Tzortzis G, Vulevic J, I'Anson K, Gibson GR. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr. 2008;87(3):785-91. doi:10.1093/ajcn/87.3.785.
Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr. 2013;143(3):324-31. doi:10.3945/jn.112.166132.
Canfora EE, van der Beek CM, Hermes GDA, Goossens GH, Jocken JWE, Holst JJ, et al. Supplementation of diet with galacto-oligosaccharides increases bifidobacteria, but not insulin sensitivity, in obese prediabetic individuals. Gastroenterology. 2017;153(1):87-97.e3. doi:10.1053/j.gastro.2017.03.051.
Beteri B, Barone M, Turroni S, Brigidi P, Tzortzis G, Vulevic J, et al. Impact of combined prebiotic galacto-oligosaccharides and Bifidobacterium breve-derived postbiotic on gut microbiota and HbA1c in prediabetic adults: a double-blind, randomized, placebo-controlled study. Nutrients. 2024;16(14):2205. doi:10.3390/nu16142205.
Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508-18. doi:10.1111/j.1365-2036.2008.03911.x.
Chen T, Long W, Zhang C, Liu S, Zhao L, Hamaker BR. Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota. Sci Rep. 2017;7:2594. doi:10.1038/s41598-017-02995-4.
Healey G, Murphy R, Butts C, Brough L, Whelan K, Coad J. Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. Br J Nutr. 2018;119(2):176-89. doi:10.1017/S0007114517003440.
Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014;20(5):779-86. doi:10.1016/j.cmet.2014.07.003.
Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12(5):303-10. doi:10.1038/nrgastro.2015.47.
Zhao G, Nyman M, Jönsson JÅ. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed Chromatogr. 2006;20(8):674-82. doi:10.1002/bmc.580.
Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8(2):172-84. doi:10.1080/19490976.2017.1290756.
